로봇 수술 시장 - 규모, 점유율, 성장률, 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of robotic surgical procedures Market

The global robotic surgical procedures market has emerged as one of the fastest-growing segments within advanced medical technologies, driven by the increasing adoption of minimally invasive surgeries and continuous innovation in surgical robotics. According to Fortune Business Insights, the market was valued at USD 13.32 billion in 2025 and is projected to expand significantly to USD 15.9 billion in 2026, reaching USD 54.61 billion by 2034, registering a robust CAGR of 16.68% during 2026-2034.

Market Overview

Robotic surgery, also referred to as robot-assisted surgery, enables surgeons to perform complex procedures with enhanced precision, flexibility, and control. These procedures are widely used in general surgery, gynecology, urology, orthopedics, and other specialties. The growing preference for minimally invasive techniques, reduced hospital stays, faster recovery times, and improved clinical outcomes are major factors accelerating the adoption of robotic surgical procedures globally.

Despite a sharp decline of -14.3% in 2020 due to the COVID-19 pandemic, the market has shown a strong recovery trajectory. The cancellation and postponement of elective surgeries during the pandemic temporarily reduced demand; however, the resumption of surgical volumes has restored growth to pre-pandemic levels.

Impact of COVID-19

The COVID-19 pandemic negatively impacted the robotic surgical procedures market due to widespread cancellation of elective surgeries. According to the CovidSurg Collaborative, approximately 28 million elective surgeries were cancelled or postponed globally during peak disruption. Additionally, leading players such as Intuitive Surgical reported a revenue decline of around -6.0% in the first half of 2020, mainly due to reduced procedure volumes and supply chain disruptions. Nevertheless, post-pandemic recovery has significantly strengthened market demand.

Market Size and Key Highlights

• 2025 Market Size: USD 13.32 billion
• 2026 Market Size: USD 15.9 billion
• 2034 Market Size: USD 54.61 billion
• CAGR (2026-2034): 16.68%

In terms of regional dominance, North America accounted for 73.89% of the global market share in 2025, driven by high procedure volumes, advanced healthcare infrastructure, favorable reimbursement policies, and rapid adoption of robotic systems.

Driving Factors

The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and orthopedic conditions is a key driver of market growth. For instance, prostate cancer cases are expected to increase steadily, leading to higher volumes of robot-assisted prostatectomy procedures. Additionally, the growing geriatric population and sedentary lifestyles are further contributing to the increased demand for surgical interventions.

Technological advancements also play a critical role. Leading companies are continuously introducing next-generation robotic systems. For example, Intuitive Surgical's FDA-approved da Vinci SP system has enabled single-port access for complex urological procedures, significantly enhancing surgical efficiency.

Market Restraints

Despite strong growth potential, the market faces challenges related to high acquisition and maintenance costs of robotic surgical systems. Annual maintenance costs for systems such as the da Vinci robot range between USD 100,000 and USD 150,000, while robotic procedures can cost USD 3,000-6,000 more than conventional laparoscopic surgeries. These cost barriers limit adoption, particularly in emerging economies.

Segmentation Analysis

By application, general surgery dominated the market, holding a 32.02% share in 2026, supported by the high volume of procedures such as hysterectomy, nephrectomy, and cardiac valve repair. Orthopedics is expected to grow at a higher CAGR due to increasing orthopedic disorders and the introduction of specialized robotic platforms. Urology and gynecology are also projected to witness strong growth during the forecast period.

Regional Insights

• North America: Market size reached USD 9.84 billion in 2025 and USD 11.58 billion in 2026.
• Europe: Growth driven by urology and orthopedic procedures; Germany and the UK markets are expanding steadily.
• Asia Pacific: Expected to register the fastest CAGR, with Japan projected to reach USD 0.52 billion in 2026, China USD 0.51 billion, and India USD 0.06 billion, supported by improving healthcare infrastructure and reimbursement reforms.

Competitive Landscape

The market is largely dominated by Intuitive Surgical, owing to its strong product portfolio and global presence. Other key players include Stryker, Medtronic, Johnson & Johnson Services, Smith & Nephew, Zimmer Biomet, and CMR Surgical. Strategic acquisitions and partnerships remain a key trend, such as Medtronic's acquisition of Digital Surgery in 2020 to strengthen AI-driven robotic platforms.

Conclusion

In conclusion, the global robotic surgical procedures market is set for exceptional growth from USD 13.32 billion in 2025 to USD 54.61 billion by 2034, fueled by rising chronic disease prevalence, technological innovation, and increasing adoption of minimally invasive surgeries. Although high system costs remain a challenge, expanding reimbursement policies and continuous product advancements are expected to sustain strong market momentum throughout the forecast period.

Segmentation

By Application

• General Surgery
• Gynecology
• Urology
• Orthopedics
• Others

By Geography

• North America (the U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
• Rest of the World

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Pricing Analysis - Major Robotic Surgical Systems, 2025
• 4.2. New Product Launches, By Key Market Players
• 4.3. Reimbursement Scenario, in Key Countries, 2025
• 4.4. Impact of COVID-19 on Robotic Surgical Procedures
• 4.5. Key Industry Developments (Mergers, Acquisitions, etc.)

5. Global Robotic Surgical Procedures Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. General Surgery
  • 5.2.2. Gynecology
  • 5.2.3. Urology
  • 5.2.4. Orthopedics
  • 5.2.5. Others
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Rest of the World

6. North America Robotic Surgical Procedures Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. General Surgery
  • 6.2.2. Gynecology
  • 6.2.3. Urology
  • 6.2.4. Orthopedics
  • 6.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada

7. Europe Robotic Surgical Procedures Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. General Surgery
  • 7.2.2. Gynecology
  • 7.2.3. Urology
  • 7.2.4. Orthopedics
  • 7.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.3.1. U.K.
  • 7.3.2. Germany
  • 7.3.3. France
  • 7.3.4. Spain
  • 7.3.5. Italy
  • 7.3.6. Scandinavia
  • 7.3.7. Rest of Europe

8. Asia pacific Robotic Surgical Procedures Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. General Surgery
  • 8.2.2. Gynecology
  • 8.2.3. Urology
  • 8.2.4. Orthopedics
  • 8.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.3.1. Japan
  • 8.3.2. China
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. Southeast Asia
  • 8.3.6. Rest of Asia Pacific

9. Rest of World Robotic Surgical Procedures Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. General Surgery
  • 9.2.2. Gynecology
  • 9.2.3. Urology
  • 9.2.4. Orthopedics
  • 9.2.5. Others

10. Competitive Analysis

• 10.1. Key Industry Developments
• 10.2. Global Market Share Analysis (2021)
• 10.3. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  • 10.3.1. Intuitive Surgical
    • 10.3.1.1. Overview,
    • 10.3.1.2. Products,
    • 10.3.1.3. SWOT Analysis,
    • 10.3.1.4. Recent Developments,
    • 10.3.1.5. Strategies,
    • 10.3.1.6. Financials (Based on Availability)
  • 10.3.2. Stryker
    • 10.3.2.1. Overview,
    • 10.3.2.2. Products,
    • 10.3.2.3. SWOT Analysis,
    • 10.3.2.4. Recent Developments,
    • 10.3.2.5. Strategies,
    • 10.3.2.6. Financials (Based on Availability)
  • 10.3.3. Smith & Nephew
    • 10.3.3.1. Overview,
    • 10.3.3.2. Products,
    • 10.3.3.3. SWOT Analysis,
    • 10.3.3.4. Recent Developments,
    • 10.3.3.5. Strategies,
    • 10.3.3.6. Financials (Based on Availability)
  • 10.3.4. Accuray Incorporated
    • 10.3.4.1. Overview,
    • 10.3.4.2. Products,
    • 10.3.4.3. SWOT Analysis,
    • 10.3.4.4. Recent Developments,
    • 10.3.4.5. Strategies,
    • 10.3.4.6. Financials (Based on Availability)
  • 10.3.5. Medtronic
    • 10.3.5.1. Overview,
    • 10.3.5.2. Products,
    • 10.3.5.3. SWOT Analysis,
    • 10.3.5.4. Recent Developments,
    • 10.3.5.5. Strategies,
    • 10.3.5.6. Financials (Based on Availability)
  • 10.3.6. CMR Surgical Ltd.
    • 10.3.6.1. Overview,
    • 10.3.6.2. Products,
    • 10.3.6.3. SWOT Analysis,
    • 10.3.6.4. Recent Developments,
    • 10.3.6.5. Strategies,
    • 10.3.6.6. Financials (Based on Availability)
  • 10.3.7. Avatera Medical GmbH
    • 10.3.7.1. Overview,
    • 10.3.7.2. Products,
    • 10.3.7.3. SWOT Analysis,
    • 10.3.7.4. Recent Developments,
    • 10.3.7.5. Strategies,
    • 10.3.7.6. Financials (Based on Availability)
  • 10.3.8. Verb Surgical Inc.
    • 10.3.8.1. Overview,
    • 10.3.8.2. Products,
    • 10.3.8.3. SWOT Analysis,
    • 10.3.8.4. Recent Developments,
    • 10.3.8.5. Strategies,
    • 10.3.8.6. Financials (Based on Availability)
  • 10.3.9. Zimmer Biomet
    • 10.3.9.1. Overview,
    • 10.3.9.2. Products,
    • 10.3.9.3. SWOT Analysis,
    • 10.3.9.4. Recent Developments,
    • 10.3.9.5. Strategies,
    • 10.3.9.6. Financials (Based on Availability)
  • 10.3.10. Others Players
    • 10.3.10.1. Overview,
    • 10.3.10.2. Products,
    • 10.3.10.3. SWOT Analysis,
    • 10.3.10.4. Recent Developments,
    • 10.3.10.5. Strategies,
    • 10.3.10.6. Financials (Based on Availability)

11. Strategic Recommendations